To further look at the downstream effects of MLCK on colitis-associated CRC, studies have found that suppression of MLCK as well as blockage of TNFR2 signaling restore tight junctions, decrease pro-tumorigenic cytokines, and reduce CAC development. The gene discussed is MYLK; the disease is colitis.